Lake Charles Clinical Trials, LLC

Lake Charles, Louisiana 70629

0 studies enrolling now · 20 studies all time

What they study most

Adult Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, Autism, Autism Spectrum Disorder, Bipolar Depression, Bipolar I Depression, Major Depressive Disorder, Schizoaffective Disorder, Schizophrenia

Studies at this site

• This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months — Stopped early
• Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) — Completed
• This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia — Completed
• Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder — Completed
• A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension — Stopped early
• Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia — Completed
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early
• A Twelve Week, Open Label Extension Study in Patients With Schizophrenia — Completed
• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
• Lurasidone Pediatric Bipolar Study — Completed
• A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. — Completed
• Open-label Safety Study in Adults With ADHD — Completed
• Pediatric Schizophrenia Efficacy and Safety Study — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• Lurasidone Pediatric Autism Study — Completed
• Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia — Completed
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents — Completed